Carregant...
P-042. Prospective and Randomized Comparison of Tenofovir and Entecavir in Hepatitis B Reactivation Prophylaxis in Patients Receiving Immunosuppressive Therapy
INTRODUCTION: Current guidelines recommend the use of prophylactic nucleoside(t)ide analogs in the prevention of Hepatitis B virus(HBV) reactivation due to immunosuppressive(IS) treatments. There is no prospective randomized study evaluating the efficacy of tenofovir disoproxil fumarate(TDF) in this...
Guardat en:
| Publicat a: | Turk J Gastroenterol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Turkish Society of Gastroenterology
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7021026/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tjg.2019.48 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|